A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease

RecruitingOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

October 25, 2019

Primary Completion Date

May 1, 2025

Study Completion Date

August 1, 2026

Conditions
Sickle Cell Disease
Interventions
DEVICE

FDNIRS-DCS

FDNIRS-DCS measurements will be performed at the same time as all MRI scans. Participants in Group 4 will have additional measurements before, during, and after the their scheduled transfusion.

DEVICE

MRI

Participants in Groups 1-3 will receive a single, hour-long MRI. Participants in Group 4 will receive two, one hour long MRI scans: one within a week prior to their transfusion and one within a week after their transfusion.

Trial Locations (1)

02115

RECRUITING

Boston Children's Hospital, Boston

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Boston Children's Hospital

OTHER

NCT04166526 - A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease | Biotech Hunter | Biotech Hunter